ExactAntigen

ExactAntigen Akt Antibody Review
back to AKT1 products
Akt 1 (also called Akt1 or protein kinase B) is one of the most studied protein kinases, and one of the most studied signalling molecules (along with ERK/MAP kinase, and p53). This is largely due to its role in the regulation of apoptotic pathway and implication in oncogenesis.
This is a review about Akt antibodies, based on 99 published articles using Akt antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited Akt antibody. Information in this review (with links to publications) can be searched freely.
list by method: flow cytometry, immunocytochemistry, immunohistochemistry, immunoprecipitation, western blot
CELL SIGNALING TECHNOLOGY    search CELL SIGNALING TECHNOLOGY AKT1 products
Other Brands or Spellings: CELL SIGNALING, NEB, NEW ENGLAND BIOLABS INC, NEW ENGLAND BIOLABS, CELL SIGNALING TECHNOLOGIES, NEW ENGLAND BIOLABS AND CELL SIGNALING TECHNOLOGY, CELL SIGNAL, CELL SIGNALLING

phospho-Akt (Serine 473)
Cell Signaling Technology rabbit polyclonal anti-phospho-Akt (Ser 473) antibody was used in immunohistochemistry in 2002 by Shazli N Malik et al. to study phospho-specific Akt expression in human prostate cancer, in 2003 by Yuichi Oike et al. to study AGF in epidermal keratinocytes and by Nobuo Noshita et al. to study copper-zinc superoxide dismutase during transient mouse focal cerebral ischemia, and in 2005 by Yen-Chung Chen et al. o investigate the activation of phosphatidylinositol 3-kinase/Akt and transformation by NBS1 and by Federico Cappuzzo et al.to study EGFR and gefitinib sensitivity in non-small-cell lung cancer.
Cell Signaling Technology phospho-Akt (S473) antibody was used in immunoprecipition in 2001 by Y Sasaki et al. to study the role of Hgs/Hrs and its interacting proteins in signaling for cytokine-mediated c-fos induction and by M J Rane et al. to study activation of p38-dependent MK2 in human neutrophils, in 2002 by Thomas Jahn et al. to study the Grb10 role in the Akt activation, in 2004 by Joao T Barata et al. to study interleukin 7 effects on T cell acute lymphoblastic leukemia cells, and in 2005 by Kin Yip Lo et al. to study the effect of SLAM-associated protein in Trk signaling.
Cell Signaling Technology phospho-Akt (S473) antibody was used in Western blot very extensively, and with a large number of publications. In 2001, A L Sirén et al. used New England Biolabs rabbit polyclonal anti-phospho-Akt/protein kinase-B (Ser-473) antibody to investigate erythropoietin effect on neuronal apoptosis after cerebral ischemia and metabolic stress; M Zang et al. to study the mechanisms of Raf-1 activation; E Asselin et al. to study the effect of XIAP on Akt activity during cisplatin-induced apoptosis in human ovarian epithelial cancer cells; D C Otero et al. to study cd19-dependent activation of Akt kinase in B-lymphocytes; C Sweeney et al. to study growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors; E Avota et al. to study the MV interference with Akt activation during immunosuppression; H Huang et al. to demonstrate the causal relationship between PTEN loss and overexpression of Bcl-2 in prostate cancer; I Fleming et al. to study the regulation of Ca2+/Calmodulin-dependent eNOS activity by the phosphorylation of eNOS Thr495; K Yu et al. to study the effect of CCI-779 on the proliferation of a panel of breast cancer cell lines. In 2002, Bernardo Yusta et al.used anti-phospho-Akt (Ser473 or Thr308) antibody in western blot to study cell survival by GLP-2R signaling; Russell D Klein et al. to study the effects of black tea polyphenols on IGF-I signal transduction pathways in normal prostate epithelial cells and Du145 prostate carcinoma cells; Anjana Saxena et al. to study induction of the human oxidized base-specific DNA glycosylase NEIL1 by reactive oxygen species; Fei Su et al. to study the mechanism by which WISP-1 promotes tumorigenicity; Ming-Hui Zou et al. to study the Akt activity and Akt phosphorylation; Veronique Baoraoziat et al. to study insulin receptor catalytic activity inhibition; Armelle Yart et al. to study the role of phosphoinositide 3-kinase beta lipid products in LPA-induced Ras activation; Henri H Versteeg et al. to study the effect of VIIa/tissue factor interaction. In 2003, Albert H Kim et al. used Cell Signaling Technologys polyclonal anti-phospho-Akt (Ser-473) antibody to study Akt1 activation; Monique C A Duyndam et al.to study the role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite; Joseph J Senn et al. to study interleukin-6-dependent insulin resistance in hepatocytes by suppressor of cytokine signaling-3 (SOCS-3); Ralf Benndorf et al. to study the inhibitory effect of the angiotensin II type 2 receptor on VEGF-induced migration and in vitro tube formation of human endothelial cells. In 2004, Hong Xia et al. used Cell Signaling Technology anti-phosphorylated Akt(p-Akt-ser473) antibody in western blot to study the levels of phosphorylated Akt (p-Akt-ser473) and total Akt in response to upstream signals in the beta 1 integrin/PI3K/Akt signal pathway; Karen L Wu et al. to study akt-dependent cell survival by the regulating of ezrin/radixin/moesin proteins; Xiao-Feng Le et al. to study gene regulation by anti-HER2 antibody; In 2005 Zhen Xu et al.used Cell Signaling Technology rabbit anti-phospho-Akt (Ser-473) antibody in western blot to study regulation of the integrin-linked kinase (ILK) level, cell shape, and survival signaling through the LIM1-mediated interaction with ILK; Takahiro Nobukuni et al. to study amino acids mediate mTOR activation by signaling through class 3 PI3K, hVps34; Susanne Urschel et al. to study the interaction of Grb10 with 14-3-3; Hitoshi Ogawa et al. to study the mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells; Kohsuke Kanekura et al. to study Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death; 2005 Konstantinos G Drosopoulos et al. to study the biological function of TRAIL induced apoptosis in human colon cells; Zheng-Gen Jin et al. to study the effect of flow shear stress on Gab1, protein kinase B, and endothelial nitric-oxide synthase in endothelial cells; Ju-Eun Oh et al. to study the beta-igh3-mediated keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin alpha-3,beta-1 and the phosphatidylinositol 3-kinase/Akt signaling pathway; Hee Yun et al. to study VEGF mRNA stability in DU145 prostate carcinoma; John R Basile et al. to investigate the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway by semaphorin 4D/plexin-B1; Annett Hahn-Windgassen et al. to investigate the interaction among Akt, mTOR, and AMPK; Rinat Arbel-Goren et al. to study galectin-8 signalling pathway; Jean-François Lavoie et al. to study the induction of neuroblastoma cell apoptosis by TrkA; Satoshi Nozawa et al. to investigate the down-regulation of phospholipase D2 in the EWS-Fli1-knocked down TC-135 cells.
phospho-Akt (Threonine 308)
In 2004, Weiya Xia et al. used New England Biolabs rabbit polyclonal anti-phospho-Akt (T308) antibody in immunohistochemistry to study HER2/neu overexpression in breast cancer patients. In 2001, M J Rane et al. used New England Biolabs anti-phospho-Thr308-Akt antibody in immunoprecipitation to study activation of p38-dependent MK2 in human neutrophils. In 2001 T Wada et al. used New England Biolabs polyclonal anti-Thr308 phospho-specific Akt antibody and polyclonal anti-Ser473 phospho-specific Akt antibody in western blot to study the effect of SH2-containing inositol phosphatase 2 in 3T3-L1 adipocytes; S Fan et al. used New England Biolabs total c-Akt(9272) and phospho-Akt (Ser-473)(9271S) antibodies in western blot to study the HGF/SF-c-Met signaling pathways for cell survival and DNA repair regulated by Gab1, and I Fleming et al.used Cell Signaling antibody against Akt/PKB as well as the phospho-specific antibodies recognizing p-Akt/PKB (Ser473) and p-Akt/PKB (Thr308) in western blot to study the regulation of Ca2+/Calmodulin-dependent eNOS activity by the phosphorylation of eNOS Thr495. In 2002, Saori Sato et al. used phospho-Akt (Thr-308) antibody in western blot to study 3-phosphoinositide-dependent protein kinase-1 activity regulation, Thomas Jahn et al. used New England Biolabs anti-phospho-Akt (Ser473 and Thr308) antibody in Western blot to study Grb10 in the Akt activation, Ming-Hui Zou et al. used Cell Signaling Akt and phospho-Akt (Thr308 or Ser473) antibodies in western blot to study the Akt activity and Akt phosphorylation, and Bernardo Yusta et al. used Cell Signaling Technology anti-phospho-Akt (Ser473 or Thr308) antibody in western blot to study cell survival by GLP-2R signaling. In 2003, Albert H Kim et al. used Cell Signaling Technologies polyclonal anti-phospho-Akt(Thr-308) antibody and polyclonal anti-phospho-Akt(Ser-473) antibody in western blot to study Akt1 activation. In 2005, Cheng Zhang et al. used Cell Signaling phospho-Akt (Thr308) and total Akt antibodies in western blot to investigate the repression of RNA polymerase I transcription by PTEN; John R Basile et al. used Cell Signaling Akt and phospho-Akt (Thr308 and Ser 473) antibodies in western blot to investigate the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway by semaphorin 4D/plexin-B1; Xiao-Feng Le et al. used Cell Signaling Technology antibodies reactive with phospho-Ser-473 AKT, phospho-Thr-308 AKT, and total AKT in western blot to study gene regulation by anti-HER2 antibody; and Zhen Xu et al. used Cell Signaling Technology rabbit anti-AKT, anti-phospho-Akt (Ser-473), and anti-phospho-Akt(Thr-308) antibodies in western blot to study regulation of the integrin-linked kinase (ILK) level, cell shape, and survival signaling through the LIM1-mediated interaction with ILK.
Akt antibody and others
Cell Signaling Technology provides both antibodies against unphosphorylated and phosphorylated AKT, which have been used extensively. In 2001, K Hisamoto et al. used New England BioLabs rabbit polyclonal anti-Akt antibody in western blot to study activation of endothelial nitric-oxide synthase induced by estrogen in vascular endothelial cells, R A Campbell et al. used it in western blot and immunoprecipitation to study activation of ER by the PI 3-kinase/AKT survival pathways. In 2002, Hong Wang et al. used Cell Signaling Technology phospho-Akt antibody in immunohistochemistry to study endometrial tumorigenesis in Pten heterozygous mice; Michael Mildner et al. used New England Biolabs monoclonal anti-phospho-AKT antibody in western blot to study the inhibition of UVB-induced apoptosis of human keratinocytes by hepatocyte growth factor/satter factor; Toshifumi Fukuda et al. used New England BioLabs anti-phospho-AKT polyclonal antibody in western blot to investigate a novel mechanism for the regulation of Rac activity and lamellipodia formation by RET tyrosine kinase; Hideki Murakami et al. used anti-Akt and anti-phosphoAkt polyclonal antibodies in western blot to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET; Heidi L Kenerson et al. used phospho-Akt antibody in western blot to study the expression of Akt in the Eker renal tumors; Christopher J Howe et al. used in western blot to study the phosphorylation of Akt; Diana Birle et al. used anti-PKB antibody in western blot to study the phosphorylation of PTEN; Mihail S Iordanov et al. used anti-phospho-PKB/Akt1 antibody in western blot to study the phosphorylation state of EGFR , ERK, and PKB/Akt1; Ming-Hui Zou et al. used Cell Signaling against phospho-Akt antibody in western blot to study the Akt activity and Akt phosphorylation; and Giuseppe Pandini et al. used New England Biolabs anti-phospho-Akt antibody in western blot to study the biological characteristics of insulin/insulin-like growth factor I hybrid receptors. In 2003, Weidong Wu et al. used Cell Signaling Technology phospho-specific Akt and Akt antibodies in western blot to study Zinc-induced PTEN protein degradation; and Hiroki Kuniyasu et al. used anti-pAKT antibody in western blot to study the production of interleukin 15 by human colon cancer cells associated with induction of mucosal hyperplasia,angiogenesis, and metastasis. In 2004 Atsushi Saito et al. used rabbit polyclonal antibody against Akt and phosphorylated Akt used in western blot to study neuroprotective role of PRAS and NGF in apoptotic neuronal cell death after stroke; and P Christian Schulze et al. used Cell Signaling anti-Akt and anti-phospho-Akt antibodies in western blot to study interaction between thioredoxin and Txnip as an important mechanism for vascular oxidative stress in diabetes mellitus. In 2005, Chaitali Basak et al. used Cell Signaling Technology Akt kinase assay kit in immunoprecipitation to evaluate the role of NF-kappa B- and C/EBP beta-driven Interleukin-1 beta gene expression and PAK1-mediated caspase-1 activation in Interleukin-1 beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages; Jean S Campbell et al. used anti-Akt antibody in western blot to study the inducing of platelet-derived growth factor C to liver fibrosis, steatosis, and hepatocellular carcinoma; Michael N Corradetti et al. used anti-Akt antibody in western blot to study the negative regulation of the mammalian target of rapamycin pathway by the stress-inducted proteins RTP801 and RTP801L; Yan Xing et al. used anti-Akt antibody (which recognizes phosphorylated proteins of Akt) in western blot to study the function of protein phosphatase subunit G5PR in B cell receptor-induced apoptosis; Minsub Shim et al. used Akt antibody and phospho-Akt antibody in Western blot to study the biological function of NAG-1 expression in LNCaP cells; Roderick J Phillips et al. used rabbit anti-human phospho-AKT antibody in western blot to study CXC chemokine receptor 4 expression in non-small cell lung cancer cells; Filippo Acconcia et al. used polyclonal anti-phospho-AKT antibody in western blot to study the physiological role of ER palmitoylation in the receptor localization to the cell membrane and in the regulation of the E2-induced cell proliferation; Laura Suomalainen et al. used p-Akt antibody in western blot to study the inhibition effect of sphingosine-1-phosphate on nuclear factor kappa B activation and germ cell apoptosis in the human testis independently of its receptors; Ilchung Shin et al. used anti-Akt and antiphosphorylated Akt antibodies in Western blot to study the biological function of Rac-MKK3/6-p38 pathway; Stefan Kippenberger et al. used anti-phosphorylated PKB/Akt (serine 473 and threonine 308) and anti-total PKB/Akt antibodies in Western blot to study the biological function of protein kinase B/Akt phosphorylation; Kip M Connor et al. used rabbit anti-human Akt and phospho-Akt antibodies in western blot to the angiogenic phenotype regulation by mitochondrial H2O2 via PTEN oxidation; Margrit Hollborn et al. used rabbit anti-human Akt was used in western blot to study the changes of retinal gene expression in proliferative vitreoretinopathy; Guillaume Bossis et al. used phospho-AKT antibody in western blot to investigate regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation; Ye Zhou et al. used anti-phospho-Akt antibody and anti-Akt antibody were used in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells; Richard Seonghun Nho et al. used polyclonal Akt antibody and anti-phosphorylated Akt antibody were used to investigate the role of integrin-linked kinase in Akt phosphorylation and fibroblast survival; and Marina K Holz et al. used anti-Akt and anti-phospho-Akt antibodies were used in western blot to identify S6 Kinase 1 as a mTOR-phosphorylating Kinase.
SIGMA    search SIGMA AKT1 products
Other Brands or Spellings: SIGMA-ALDRICH, SIGMA CHEMICAL, SIGMA CHEMICAL COMPANY, SIGMA-ALDRICH FINE CHEMICALS
In 2005, Rinat Arbel-Goren et al. used Sigma polyclonal PKB (Akt) antibody in western blot to study galectin-8 signalling pathway.
SANTA CRUZ BIOTECHNOLOGY
Other Brands or Spellings: SANTA CRUZ, SANTA CRUZ BIOTECH, SANTA CRUZ BIOTECHNOLOGY INC., SANTA CRUZ BIOTECHNOLOGY INC, SANTZ CRUZ, SANTA CRUZ BIOTECHNOLOGIES
In 2002 Shyra Gardai et al. used Santa Cruz Biotechnology anti-Akt antibody in flow cytometry and western blot to study the role of oxidants and Lyn in SHIP regulation. In 2002, Shazli N Malik et al. used Santa Cruz Biotechnology rabbit polyclonal anti-Akt antibody in immunohistochemistry to study the expression of phospho-specific Akt in human prostate cancer. In 2001, T Wada et al. used Santa Cruz Biotechnology polyclonal anti-Akt antibody in western blot and immunoprecipitation to study the effect of SH2-containing inositol phosphatase 2 in 3T3-L1 adipocytes, and E Avota et al. used it to study the MV interference with Akt activation during immunosuppression. In 2002, Thomas Jahn et al. used Santa Cruz Biotechnology polyclonal anti-Akt antibody in immunoprecipitation to study the biological roles of Grb10 in the activation of Akt. Santa Cruz Biotechnology Akt antibody was used in western blot in 2002 by Veronique Baoraoziat et al.to study insulin receptor catalytic activity inhibition, by Henri H Versteeg et al. to study the effect of VIIa/tissue factor interaction, by Mihail S Iordanov et al. to study the phosphorylation state of EGFR, ERK, and PKB/Akt1, in 2003 by Hiroki Kuniyasu et al. to study the production of interleukin 15 by human colon cancer cells associated with induction of mucosal hyperplasia,angiogenesis, and metastasis, and in 2005 by Susanne Urschel et al. wb Santa Cruz Biotechnology goat anti-Akt C-20 antibody was used in western blot to study the interaction of Grb10 with 14-3-3. Santa Cruz Biotechnology monoclonal anti-AKT antibody was used in western blot in 2004 by Karen L Wu et al. to study akt-dependent cell survival by the regulating of ezrin/radixin/moesin Proteins, and in 2005 by Filippo Acconcia et al. to study the physiological role of ER palmitoylation in the receptor localization to the cell membrane and in the regulation of the E2-induced cell proliferation. Loredana Moro et al. used polyclonal rabbit anti-phospho-AKT-Ser-473 antibody antibody in western blot to study the effect of down-regulation of BRCA2 expression by collagen type I in 2005.
UPSTATE BIOTECHNOLOGY
Other Brands or Spellings: CHEMICON, UPSTATE BIOTECHNOLOGIES, UPSTATE, CHEMICON INTERNATIONAL, UPSTATE CELL SIGNALING, UPSTATE CELL SIGNALING SOLUTIONS, UPSTATE BIOTECH, UPSTATE BIOTECHNOLOGY INC, UPSTATE LABORATORIES
Shyra Gardai et al. used Upstate Biotechnology anti-phospho-Akt antibody in flow cytometry and western blot to study the role of oxidants and Lyn in SHIP regulation in 2002. Upstate Biotechnology anti-PKB antibody was used in western blot and immunoprecipitation by X Pesesse et al. to study inositol 5-phosphatase SHIP2 recruitment in EGF-stimulated COS-7 cells in 2001, and by Eijiro Yamada et al. to study phosphorylation of Synip by Akt2 to regulate docking and fusion of GLUT4-containing vesicles in 2005. In 2002, Diana Birle et al. used Upstate Biotechnology anti-PKB-phospho Ser473 antibody in western blot to study the phosphorylation of PTEN, and Maria Diakonova et al. used Upstate Biotechnology anti-alphaRac antibody (clone 238A8) in western blot to study cellular motility by recruiting Rac and potentially Rac-regulating. In 2003 Monique C A Duyndam et al. used sheep polyclonal Akt-1 antibody in western blot to study the role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite, and Lilly Y W Bourguignon et al. used mouse anti-AKT-1 antibody in western blot to study CD44 interaction with p115RhoGEF in human metastatic breast tumor cells. In 2004, Cynthia M Grimsley et al. used Upstate Biotechnology mouse monoclonal anti-Rac antibody (clone 23A8) in western blot to study the cooperation of Dock180 and ELMO1 proteins to promote evolutionarily conserved rac-dependent cell migration. In 2005, Xiao-Feng Le et al. used Upstate Biotechnology AKT1 antibody in western blot to study gene regulation by anti-HER2 antibody, and Yi Qin et al. to study the function of the mammalian scribble polarity protein to regulate epithelial cell adhesion and migration through E-cadherin.
BD TRANSDUCTION LABORATORIES
Other Brands or Spellings: BD BIOSCIENCES, BD, BD BIOSCIENCES CLONTECH, BD BIOSCIENCES PHARMINGEN, BD TRANSDUCTION LABORATORY, TRANSDUCTION LABORATORIES, PHARMINGEN, PHARMINOGEN, BD PHARMINGEN, BECTON DICKINSON, TRANSDUCTION LABORATORY, BECTON DICKINSON TRANSDUCTION LABORATORIES, BD TRANSDUCTION
In 2001, Y Sasaki et al. used BD Transduction Laboratories anti-Akt antibody in western blot and immunoprecipition to study the role of Hgs/Hrs and its interacting proteins in signaling for cytokine-mediated c-fos induction. In 2003, DiAnna L Hynds et al. used BD Transduction Laboratories monoclonal anti-Akt antibody in western blot to study the role of Rit in human neuroblastoma cells for MEK-independent neurite branching. In 2005, Bruno Canguilhem et al. used BD Biosciences phospho-AKT (Ser-472/Ser-473/Ser-474) and AKT antibodies in western blot to study RhoB protective effect from UVB-induced apoptosis in human keratinocytes. Sylvia Major et al. tested BD Transduction PKBa/AKT antibody in western blot in the Abminer project in 2006.
EPITOMICS
In 2006, A Persson et al. tested Epitomics AKT1 antibody in immunohistochemistry in the HPA (CAB003765) project.
R&D SYSTEMS
Other Brands or Spellings: R & D SYSTEMS, R&D, RNDSYSTEMS, R & D SYSTEM
DiAnna L Hynds et al. used R&D Systems polyclonal anti-phospho-Akt antibody in western blot to study the role of Rit in human neuroblastoma cells for MEK-independent neurite branching in 2003.
BIOSOURCE INTERNATIONAL
Other Brands or Spellings: INVITROGEN, BIOSOURCE, ZYMED, ZYMED LABORATORIES, CALTAG, MOLECULAR PROBES, MEDGENIX DIAGNOSTICS, MEDGENIX, DYNAL ASA
In 2001, D Camper-Kirby et al. used Biosource International antibody to phospho-Akt(serine473) in western blot and immunohistochemistry to study the difference between sexes in myocardial activation of Akt.
ATLAS ANTIBODIES
In 2006, A Persson et al. tested Atlas Antibodies AKT1 antibody in immunohistochemistry in the HPA (CAB003765) project.


Articles Reviewed
1. D C Otero et al. Cd19-dependent activation of Akt kinase in B-lymphocytes. 2001
2. M J Rane et al. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. 2001
3. K Hisamoto et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. 2001
4. R A Campbell et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. 2001
5. T Wada et al. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity. 2001
6. A L Sirén et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. 2001
7. M Zang et al. Microtubule integrity regulates Pak leading to Ras-independent activation of Raf-1. insights into mechanisms of Raf-1 activation. 2001
8. E Asselin et al. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. 2001
9. C Sweeney et al. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. 2001
10. C Jiang et al. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. 2001
11. X Pesesse et al. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. 2001
12. D Camper-Kirby et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. 2001
13. E Avota et al. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. 2001
14. I Fleming et al. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. 2001
15. Y Sasaki et al. Involvement of Hgs/Hrs in signaling for cytokine-mediated c-fos induction through interaction with TAK1 and Pak1. 2001
16. S Fan et al. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. 2001
17. H Huang et al. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. 2001
18. K Yu et al. mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. 2001
19. Shyra Gardai et al. Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. 2002
20. Veronique Béréziat et al. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. 2002
21. Russell D Klein et al. Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. 2002
22. Fei Su et al. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. 2002
23. Maria Diakonova et al. SH2-Bbeta is a Rac-binding protein that regulates cell motility. 2002
24. Thomas Jahn et al. Role for the adaptor protein Grb10 in the activation of Akt. 2002
25. Michael Mildner et al. Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway. 2002
26. Toshifumi Fukuda et al. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. 2002
27. Armelle Yart et al. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. 2002
28. Hong Wang et al. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. 2002
29. Shazli N Malik et al. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. 2002
30. Bernardo Yusta et al. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. 2002
31. Henri H Versteeg et al. VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation. 2002
32. Christopher J Howe et al. Participation of the calcium/calmodulin-dependent kinases in hydrogen peroxide-induced Ikappa B phosphorylation in human T lymphocytes. 2002
33. Diana Birle et al. Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. 2002
34. Hideki Murakami et al. Role of Dok1 in cell signaling mediated by RET tyrosine kinase. 2002
35. Mihail S Iordanov et al. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. 2002
36. Ming-Hui Zou et al. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. 2002
37. Giuseppe Pandini et al. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. 2002
38. Saori Sato et al. Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3. 2002
39. Anjana Saxena et al. Phosphoinositide binding by the pleckstrin homology domains of Ipl and Tih1. 2002
40. Heidi L Kenerson et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. 2002
41. Monique C A Duyndam et al. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. 2003
42. Joseph J Senn et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. 2003
43. DiAnna L Hynds et al. Rit promotes MEK-independent neurite branching in human neuroblastoma cells. 2003
44. Nobuo Noshita et al. Copper-zinc superoxide dismutase affects Akt activation after transient focal cerebral ischemia in mice. 2003
45. Weidong Wu et al. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. 2003
46. Lilly Y W Bourguignon et al. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progressio. 2003
47. Albert H Kim et al. JNK-interacting protein 1 promotes Akt1 activation. 2003
48. Yuichi Oike et al. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration. 2003
49. Ralf Benndorf et al. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. 2003
50. Hiroki Kuniyasu et al. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. 2003
51. Cynthia M Grimsley et al. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. 2004
52. Atsushi Saito et al. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. 2004
53. Karen L Wu et al. The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. 2004
54. P Christian Schulze et al. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. 2004
55. Hong Xia et al. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. 2004
56. Weiya Xia et al. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. 2004
57. Joao T Barata et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. 2004
58. Hitoshi Ogawa et al. Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. 2005
59. Filippo Acconcia et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. 2005
60. Xiao-Feng Le et al. Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling. 2005
61. Stefan Kippenberger et al. Mechanical stretch stimulates protein kinase B/Akt phosphorylation in epidermal cells via angiotensin II type 1 receptor and epidermal growth factor receptor. 2005
62. Chaitali Basak et al. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. 2005
63. Kohsuke Kanekura et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. 2005
64. Michael N Corradetti et al. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. 2005
65. Hee Yun et al. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. 2005
66. Zheng-Gen Jin et al. Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells. 2005
67. Ilchung Shin et al. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. 2005
68. Kip M Connor et al. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. 2005
69. Susanne Urschel et al. Phosphorylation of grb10 regulates its interaction with 14-3-3. 2005
70. Jean S Campbell et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. 2005
71. Laura Suomalainen et al. Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors. 2005
72. Rinat Arbel-Goren et al. Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8. 2005
73. Eijiro Yamada et al. Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. 2005
74. Konstantinos G Drosopoulos et al. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway. 2005
75. Minsub Shim et al. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. 2005
76. Roderick J Phillips et al. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia ind. 2005
77. Ju-Eun Oh et al. Beta ig-h3 induces keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin alpha3beta1 and the phosphatidylinositol 3-kinase/Akt signaling pathway. 2005
78. Loredana Moro et al. Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation. 2005
79. Federico Cappuzzo et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. 2005
80. Marina K Holz et al. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. 2005
81. Richard Seonghun Nho et al. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway. 2005
82. Satoshi Nozawa et al. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. 2005
83. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005
84. Zhen Xu et al. Molecular dissection of PINCH-1 reveals a mechanism of coupling and uncoupling of cell shape modulation and survival. 2005
85. Jean-François Lavoie et al. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. 2005
86. Margrit Hollborn et al. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. 2005
87. Annett Hahn-Windgassen et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. 2005
88. Yen-Chung Chen et al. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. 2005
89. Elizabeth L Tudor et al. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. 2005
90. John R Basile et al. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. 2005
91. Cheng Zhang et al. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex. 2005
92. Guillaume Bossis et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. 2005
93. Yan Xing et al. Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis. 2005
94. Takahiro Nobukuni et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. 2005
95. Kin Yip Lo et al. SLAM-associated protein as a potential negative regulator in Trk signaling. 2005
96. Bruno Canguilhem et al. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. 2005
97. Yi Qin et al. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. 2005
98. Sylvia Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006
99. A Persson et al. A human protein atlas based on antibody proteomics. 2006


2007 ©ExactAntigen ExactAntigen home | Browse | About ExactAntigen